» Articles » PMID: 36291136

Key Genes Associated with Pyroptosis in Gout and Construction of a MiRNA-mRNA Regulatory Network

Overview
Journal Cells
Publisher MDPI
Date 2022 Oct 27
PMID 36291136
Authors
Affiliations
Soon will be listed here.
Abstract

Methods: The GSE160170 dataset was downloaded from the GEO database. The expression data extracted from the dataset were used to screen for differentially expressed genes (DEGs), which intersected with pyroptosis-related genes. These DEGs were analyzed via Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses, and a protein-protein interaction (PPI) network was constructed to identify pyroptosis-related hub DEGs. The relationship between upstream miRNAs and the hub genes was analyzed, miRNA-mRNA networks belonging to gout disease were constructed and samples from patients with gout were used for experimental verification. The CTDbase tool was used to analyze the identified hub genes and construct a molecular docking model.

Results: A total of 943 DEGs (380 upregulated and 563 downregulated) were identified by analyzing the data of patients with early-stage gout and healthy control individuals in the GSE160170 dataset. DEGs and pyroptosis-related genes were intersected to obtain 17 pyroptosis-related DEGs associated with gout; of which, 12 were upregulated, and five were downregulated. The results of GO and KEGG analyses revealed that the DEGs were enriched in inflammatory and immune signaling pathways. Additionally, the DEGs were found to regulate inflammatory responses and were associated with apoptosis. , and were identified as key hub genes in the PPI network, and a miRNA-mRNA network was constructed, which had 16 edges. Experimental validation revealed that and were significantly upregulated, and and were significantly downregulated in gout. In addition, miR-128-3p, miR-16-5p, miR-155-5p, and miR-20a-5p (associated with the miRNA-mRNA regulatory network) were significantly downregulated in gout. Five potential therapeutic drugs with stable binding were selected to develop a molecular docking model.

Conclusion: A miRNA-mRNA potential regulatory network was constructed based on pyroptosis-related DEGs associated with gout. miR-16-5p, miR-128-3p, miR-20a-5p, and miR-155-5p can potentially influence pyroptosis and the occurrence and development of gout by affecting the expression of the , , , and genes. Screening of celecoxib and resveratrol and other targeted drugs with stable binding. The findings of this study offer valuable insights into the regulatory mechanisms of gout and may help to identify Biomarkers and develop targeted therapeutic strategies for gout.

Citing Articles

Mechanism of ShuiJingDan in Treating Acute Gouty Arthritis Flares Based on Network Pharmacology and Molecular Docking.

Liu Q, Li L, Zheng D, Jin S, Guan X, Fu Z Drug Des Devel Ther. 2023; 17:3493-3505.

PMID: 38034481 PMC: 10683514. DOI: 10.2147/DDDT.S436360.

References
1.
Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z . Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol. 2011; 29(36):4781-8. DOI: 10.1200/JCO.2011.38.2697. View

2.
Wei Q, Lv F, Zhang H, Wang X, Geng Q, Zhang X . MicroRNA-101-3p inhibits fibroblast-like synoviocyte proliferation and inflammation in rheumatoid arthritis by targeting PTGS2. Biosci Rep. 2020; 40(1). PMC: 6960065. DOI: 10.1042/BSR20191136. View

3.
Tummers B, Mari L, Guy C, Heckmann B, Rodriguez D, Ruhl S . Caspase-8-Dependent Inflammatory Responses Are Controlled by Its Adaptor, FADD, and Necroptosis. Immunity. 2020; 52(6):994-1006.e8. PMC: 7306001. DOI: 10.1016/j.immuni.2020.04.010. View

4.
Ma Q . Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013; 53:401-26. PMC: 4680839. DOI: 10.1146/annurev-pharmtox-011112-140320. View

5.
Fritsch M, Gunther S, Schwarzer R, Albert M, Schorn F, Werthenbach J . Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature. 2019; 575(7784):683-687. DOI: 10.1038/s41586-019-1770-6. View